Upload Avatar (500 x 500)
Xiaokun Zhang
English, Chinese
Fujian
Xiamen University
Life Sciences
  • 1982 - Bachelor's Degree in Biology: Xiamen University
  • 1989 - Ph.D. in Biochemistry: University of Vermont
  • Developed the first anti-cancer patented drug targeting nuclear receptor RXR, Targretin®
  • 1989 - 2006 - Sanford-Burnham Institute for Medical Research - Postdoctoral, Assistant Professor, Associate Professor, Professor
  • 2006 - Present - Xiamen University - Dean of Biomedical Research Institute, Dean of School of Pharmacy, Professor of School of Life Sciences
Nuclear hormone receptors
Vitamin A and retinoids in cancer therapy
Apoptosis signaling pathways
Nuclear Receptors Rxr Retinoids Cancer Therapy Apoptosis Signaling Pathways Drug Development Patented Drugs Targretin Non-Genomic Mechanisms

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.